Clinical Efficacy and Results Clinical trial data for both Retatrutide and Mounjaro demonstrate significant weight loss efficacy, though through different therapeutic approaches
January is the perfect time to reset, refocus, and take the first steps toward achieving your health and weight loss goals
Glucagon-like peptide-1 (GLP-1) receptor agonists are licensed for type 2 diabetes and weight management, not inflammatory conditions
Clinical trial data shows retatrutide produces greater weight loss than either semaglutide or tirzepatide at their respective maximum doses
Whether the more modest GLP-1 increase from Pendulum produces similar effects is unknown
The practical distinction: Those considering any supplement in this category should understand that dietary supplements are intended to complement, not replace, healthy lifestyle habits